PriceTracker GLP-1

GLP-1 hair loss: what is actually going on

Hair shedding on a GLP-1 is real, and the labels now count it: 3.3% of people on Wegovy 2.4 mg and 5.8% on 7.2 mg, against 1% on placebo, most of them women. Wegovy's and Zepbound's labels both say it was associated with weight reduction. Rapid weight loss is a long-recognised trigger for a temporary shedding phase, after bariatric surgery and crash dieting too. Two things make it more likely: how fast you are losing, and whether you eat enough protein and micronutrients.

5 min read · published August 2026, updated October 2026

Studio still life: a glass of water, a plain white plate and a folded napkin

Key takeaways

  • 1Wegovy's label reports hair loss in 3.3% on 2.4 mg and 5.8% on 7.2 mg (1% on placebo), and both it and Zepbound's label say it was associated with weight reduction.
  • 2The same pattern follows bariatric surgery, illness and crash dieting.
  • 3It is usually temporary, though the timeline varies and it can start months after the trigger.
  • 4Rate of loss and adequate nutrition are the two things anyone actually influences.

Hair shedding on a GLP-1 is real, the labels now count it, and the two that report it link it to weight reduction. It is what a body does after losing weight quickly, and it happens after bariatric surgery, serious illness and aggressive dieting too.

Worth knowing

General information, not medical advice. Hair loss has many causes, some of which have nothing to do with weight or GLP-1s and some of which are worth investigating. If it is significant or it worries you, see a clinician rather than a website.

What the labels say

More than they used to, and the detail fits the weight-loss explanation.

Ozempic, dosed for type 2 diabetes, does not list hair loss among the common reactions from its trials. Those are all gastrointestinal:1

The most common adverse reactions reported in ≥5% of patients treated with OZEMPIC are: nausea, vomiting, diarrhea, abdominal pain and constipation.

It does list alopecia among reactions reported after approval, a list the label says comes from voluntary reports, where "it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure."1

Wegovy, the same molecule at weight-loss doses, counts it in its trials and names the link:2

Hair loss adverse reactions in WEGOVY injection-treated patients were associated with weight reduction. In a pool of studies 2, 3, and 4, hair loss was reported in 3.3% of patients treated with WEGOVY 2.4 mg (4% female, 0.9% male) and in 1% of patients treated with placebo (2% female, 0 male).

In the trials of the 7.2 mg dose, hair loss was reported by 5.8% on 7.2 mg (8.4% of women, 0.2% of men), 3.3% on 2.4 mg and 1.0% on placebo, and hair loss is now on the label's list of the most common reactions.2 Zepbound's label uses the same words, "associated with weight reduction", and reports hair loss in 7.1% of women against 0.5% of men.3

So it is a documented side effect, more common at higher doses and in women, and the two labels that report it both describe it as associated with weight reduction. That is the mechanism below, not a separate one.

The mechanism that is documented

Hair grows in cycles, and at any moment most of your follicles are growing while a minority are resting and shedding. A significant physiological stress, and rapid weight loss is one, can push an unusually large share of follicles into the resting phase at once. Months later they shed together, and what you notice is not slow thinning but a sudden alarming amount of hair in the shower.

In plain English

The delay is the confusing part. The shedding often starts two to four months after the trigger, so people connect it to whatever they were doing that week rather than to the weight they lost in spring.

That pattern is well recognised after bariatric surgery and after crash dieting, both of which involve exactly the same trigger and no GLP-1 at all. It is generally temporary, because the follicles are resting rather than gone.

A dermatologist going through what the research actually shows on shedding and GLP-1s. Useful for the mechanism and for how uncertain parts of it still are. One clinician reading the literature, not a study in itself.

The two things you influence

How fast you are losing. The same lever as with facial volume, and the same conversation with a prescriber: dose, how quickly you climb, and whether a slower rate suits your goal. On brand pricing a slower climb costs nothing extra, which is worth knowing before you decide to tough it out.

Whether you are eating enough. These drugs work partly by making you want less food, which is the point, and it makes undereating easy to do without noticing. Protein and micronutrient intake is the thing dietitians raise first here, and "am I actually eating enough" is a reasonable and specific question to bring to a clinician or a registered dietitian.

No protein target or supplement is going in this article. Anyone confidently giving you a number on a page like this one is guessing, and the honest answer depends on your body and what else is going on with you.

What does not help

The same thing we said about facial volume, because the same industry sells into both: there is no shampoo, supplement or oil with credible evidence of preventing shedding driven by rapid weight loss. Pages ranking for this term that end in a product recommendation are selling one.

Where this touches cost, honestly

Only in one place, and we would rather say so than manufacture a reason to link.

The thing that makes shedding more likely is losing fast, and the thing that makes people lose fast in bursts is losing, stopping because the plan got expensive, and starting again. Steady beats stop-start for hair the same way it does for skin. A program you can still afford in month twelve is the version of this that does not repeat.

The short version

Real, counted in the labels, tied there to weight reduction, probably temporary, and worth checking with a clinician if it is significant, because plenty of other things cause hair loss and some of them are treatable.

Sources3
  1. Ozempic prescribing information (DailyMed): most common adverse reactions, and section 6.2, postmarketing experience read October 2026“The most common adverse reactions reported in ≥5% of patients treated with OZEMPIC are: nausea, vomiting, diarrhea, abdominal pain and constipation. ... The following adverse reactions have been reported during post-approval use of semaglutide, the active ingredient of OZEMPIC. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. ... Skin and Subcutaneous Tissue: alopecia” ↩
  2. Wegovy prescribing information (DailyMed): section 6.1, hair loss, and the most common adverse reactions read October 2026“Hair loss adverse reactions in WEGOVY injection-treated patients were associated with weight reduction. In a pool of studies 2, 3, and 4, hair loss was reported in 3.3% of patients treated with WEGOVY 2.4 mg (4% female, 0.9% male) and in 1% of patients treated with placebo (2% female, 0 male). ... In clinical trials with WEGOVY 7.2 mg injection, hair loss was reported in 5.8% of patients treated with WEGOVY 7.2 mg (8.4% female, 0.2% male), 3.3% of patients treated with WEGOVY 2.4 mg (5.4% female, 0 male), and 1.0% of patients on placebo (1.5% female, 0 male). ... Most common adverse reactions (incidence ≥5%) in adults or pediatric patients aged 12 years and older are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss.” ↩
  3. Zepbound prescribing information (DailyMed), section 6.1, hair loss read October 2026“Hair loss adverse reactions in ZEPBOUND-treated patients were associated with weight reduction. In a pool of Study 1 and 2, hair loss was reported more frequently in female than male patients in the ZEPBOUND (7.1% female versus 0.5% male) and placebo (1.3% female versus 0% male) treatment groups.” ↩

Common questions

Does Ozempic cause hair loss?

Ozempic's label does not list hair loss among the common reactions in its diabetes trials, but it lists alopecia among reports received after approval. Wegovy, the same molecule at higher doses, reports hair loss in 3.3% of people on 2.4 mg and 5.8% on 7.2 mg against about 1% on placebo, and its label says hair loss was associated with weight reduction. The same shedding pattern follows bariatric surgery and crash dieting.

Is GLP-1 hair loss permanent?

Shedding driven by rapid weight loss is generally temporary, because the follicles have entered a resting phase rather than been lost. Timelines vary considerably between people. Persistent or patchy loss is a reason to see a clinician, since many other causes exist.

When does the shedding start?

Commonly a couple of months after the trigger rather than during it, which is why people often connect it to the wrong thing. The delay between rapid weight loss and visible shedding is the most confusing part of this for most people.

Can I prevent it?

The two factors anyone actually influences are the rate of weight loss, which is a prescriber conversation about dose and titration, and whether you are eating enough protein and micronutrients while your appetite is suppressed, which is a question for a clinician or a registered dietitian. No shampoo or supplement has credible evidence of preventing shedding caused by rapid weight loss.

Does it happen on Wegovy, Mounjaro and compounded versions too?

Yes. Wegovy's and Zepbound's labels both report it and both describe it as associated with weight reduction; on Zepbound it was reported by 7.1% of women and 0.5% of men. Mounjaro is the same molecule as Zepbound, and compounded versions are the same molecules, so any program producing substantial rapid loss can produce the same shedding.

When you are ready to look at costs, our list of online GLP-1 programs and the cheapest GLP-1 page both show prices with the date we last checked them.

Read next